Zhejiang Hisern Medical Device Co (BJSE:920166) ROCE %: 13.15% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920166 Zhejiang Hisern Medical Device Co Ltd BJSE:920166
20 GF Score
Price ¥20.59
! 1 Warning Sign
View Full Analysis

What is Zhejiang Hisern Medical Device Co ROCE %?

Zhejiang Hisern Medical Device Co BJSE:920166 20 ROCE % is 13.15% as of Jun. 2026. GuruFocus rates BJSE:920166 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Hisern Medical Device Co's annualized ROCE % for the quarter that ended in Jun. 2026 was 13.15%.

Zhejiang Hisern Medical Device Co  (BJSE:920166) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Hisern Medical Device Co ROCE % Related Terms

Zhejiang Hisern Medical Device Co ROCE % Historical Data

* Premium members only.

The historical data trend for Zhejiang Hisern Medical Device Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Hisern Medical Device Co ROCE % Chart

Zhejiang Hisern Medical Device Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
31.86 29.84 21.37 20.58

Zhejiang Hisern Medical Device Co Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.33 20.82 -111.71 10.15 13.15
BJSE:920166
20GF Score
Zhejiang Hisern Medical Device Co Ltd BJSE:920166
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Hisern Medical Device Co ROCE % Calculation

Zhejiang Hisern Medical Device Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=97.756/( ( (496.046 - 64.15) + (596.511 - 78.401) )/ 2 )
=97.756/( (431.896+518.11)/ 2 )
=97.756/475.003
=20.58 %

Zhejiang Hisern Medical Device Co's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=84.632/( ( (705.48 - 61.499) + (703.382 - 59.945) )/ 2 )
=84.632/( ( 643.981 + 643.437 )/ 2 )
=84.632/643.709
=13.15 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.15% mean?
Zhejiang Hisern Medical Device Co (BJSE:920166) has a ROCE % of 13.15% as of Jun. 2026.
Is Zhejiang Hisern Medical Device Co's ROCE % too high?
Zhejiang Hisern Medical Device Co's current ROCE % is 13.15%. The Medical Devices & Instruments industry median ROCE % is 3.31. Zhejiang Hisern Medical Device Co's value of 13.15% is 297.3% above this industry median. Overall, Zhejiang Hisern Medical Device Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisern Medical Device Co's ROCE % compare to ABT and SYK?
Zhejiang Hisern Medical Device Co's ROCE % of 13.15% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 3.31. Zhejiang Hisern Medical Device Co's value of 13.15% is 297.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 3.31, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisern Medical Device Co's current ROCE % of 13.15% is 297.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisern Medical Device Co's current ROCE % is 13.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisern Medical Device Co stock overvalued right now?
Zhejiang Hisern Medical Device Co (BJSE:920166) has a current ROCE % of 13.15%. The current ROCE % is 13.15% and 297.3% above the Medical Devices & Instruments industry median of 3.31. Zhejiang Hisern Medical Device Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zhejiang Hisern Medical Device Co (BJSE:920166), the current ROCE % is 13.15% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Hisern Medical Device Co Business Description

Address No. 8, Zhenyuan Road, Yuecheng District, Zhejiang Province, Shaoxing, CHN, 312000
Zhejiang Hisern Medical Device Co Ltd is engaged in the research and development, manufacturing, and sale of anesthesia and patient monitoring medical devices. The company's offerings include Analgesic series products, airway and respiratory management series products, spinal canal and nerve block series products and carbon dioxide absorber series products for anesthesia machines.
20GF Score

Get the complete analysis for BJSE:920166

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.59
Price